Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex.

McNamee, Eoin N

Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. [electronic resource] - Neuropharmacology - 37-48 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-7064

10.1016/j.neuropharm.2010.03.014 doi


Adrenergic beta-2 Receptor Agonists
Adrenergic beta-2 Receptor Antagonists
Adrenergic beta-Agonists--pharmacology
Animals
Apoptosis--drug effects
Cerebral Cortex--drug effects
Clenbuterol--pharmacology
Cytokines--metabolism
Encephalitis--drug therapy
Interleukin 1 Receptor Antagonist Protein--metabolism
Interleukin-1beta--metabolism
Male
Neuroimmunomodulation--drug effects
Norepinephrine--metabolism
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, beta--metabolism
Receptors, Adrenergic, beta-2--metabolism
Receptors, Interleukin-1 Type II--metabolism
Signal Transduction--drug effects